Cargando…
Efficacy and Safety of Immunosuppressive Therapy for PBC–AIH Overlap Syndrome Accompanied by Decompensated Cirrhosis: A Real-World Study
AIM: To explore the efficacy and safety of immunosuppressive therapy for the treatment of primary biliary cirrhosis-autoimmune hepatitis (PBC-AIH) overlap syndrome accompanied by decompensated cirrhosis. METHODS: A cohort study was performed to evaluate the usefulness of immunosuppressive therapy in...
Autores principales: | Fan, Xiaoli, Zhu, Yongjun, Men, Ruoting, Wen, Maoyao, Shen, Yi, Lu, Changli, Yang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098853/ https://www.ncbi.nlm.nih.gov/pubmed/30155449 http://dx.doi.org/10.1155/2018/1965492 |
Ejemplares similares
-
Noninvasive diagnosis of AIH/PBC overlap syndrome based on prediction models
por: Wang, Kailing, et al.
Publicado: (2022) -
Combination therapy of ursodeoxycholic acid and budesonide for PBC–AIH overlap syndrome: a meta-analysis
por: Zhang, Huawei, et al.
Publicado: (2015) -
Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS)
por: Nguyen, Henry H., et al.
Publicado: (2018) -
A meta-analysis of ursodeoxycholic acid therapy versus combination therapy with corticosteroids for PBC-AIH-overlap syndrome: evidence from 97 monotherapy and 117 combinations
por: Zhang, Huawei, et al.
Publicado: (2015) -
Primary Biliary Cholangitis (PBC)-Autoimmune Hepatitis (AIH) Variant Syndrome: Clinical Features, Response to Therapy and Long-Term Outcome
por: Graf, Markus, et al.
Publicado: (2023)